News & Videos - EVOLENT HEALTH INC CLASS A - English

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 PR Newswire WASHINGTON, Dec. 18, 2024 Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025 . Dr. Nguyen joined Evolent as...

Evolent Announces Third Quarter 2024 Results PR Newswire WASHINGTON, Nov. 7, 2024 Revenue of $621.4 million , an increase of $110.4 million or 21.6% , from the three months ended September 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) million and a net loss margin of (5.0)% . Adjusted EBITDA of $31.8 million resulting in an Adjusted EBITDA margin of 5.1% . Revises outlook for Adjusted EBITDA for 2024. Reiterates average annual long-term revenue and...

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 PR Newswire WASHINGTON, Oct. 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON , Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2024 financial results on Thursday,...

Evolent Announces Second Quarter 2024 Results PR Newswire WASHINGTON, Aug. 8, 2024 Revenue of $647.1 million , an increase of $178.0 million or 37.9% , from the three months ended June 30, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and a net loss margin of (1.0)% . Adjusted EBITDA of $52.0 million resulting in an Adjusted EBITDA margin of 8.0% . Narrows revenue outlook for full year 2024 and provides updated 2024 Adjusted EBITDA guidance....

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire WASHINGTON, July 11, 2024 Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday,...

Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify PR Newswire WASHINGTON, June 4, 2024 Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automation Machinify technology leverages the latest advances in applied machine learning, large language models and data analytics Acquisition expected to benefit health...

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S. PR Newswire WASHINGTON, May 9, 2024 Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigation Evolent will embed Careology's digital cancer care technology within its comprehensive care navigation services offered to health plan clients across the U.S. WASHINGTON , May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a $2...

Evolent Announces First Quarter 2024 Results PR Newswire WASHINGTON, May 9, 2024 Revenue of $639.7 million , an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million and a net loss margin of (3.9)%. Adjusted EBITDA of $54.1 million resulting in an Adjusted EBITDA margin of 8.5%. Raises revenue outlook for full year 2024 and reiterates full year 2024 Adjusted EBITDA guidance....

Evolent Announces Fourth Quarter and Full Year 2023 Results Full year revenue of $1,963.9 million, 45% growth over 2022 Net loss attributable to common shareholders of Evolent Health, Inc. of $(142.3) million Adjusted EBITDA of $194.7 million, 84% growth over 2022 2023 cash flow from operations of $142.6 million Provides initial outlook for 2024 in line with long-term targets PR Newswire WASHINGTON, Feb. 22, 2024 WASHINGTON , Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a...

Evolent Adds Russell Glass, Headspace CEO, to Board of Directors PR Newswire WASHINGTON, Feb. 14, 2024 WASHINGTON , Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a successful technology and health care executive who...

Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024 PR Newswire WASHINGTON, Jan. 25, 2024 Company to Participate in Upcoming Investor Conferences WASHINGTON , Jan. 25, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its fourth quarter 2023 financial results on...

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan PR Newswire WASHINGTON, Dec. 5, 2023 WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50%...

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan PR Newswire WASHINGTON, Dec. 5, 2023 WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced that it intends to offer $350.0 million aggregate principal...

Evolent Announces Third Quarter 2023 Results PR Newswire WASHINGTON, Nov. 2, 2023 WASHINGTON , Nov. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended September 30, 2023. Highlights from the third quarter 2023 announcement include: Revenue of $511.0 million , an increase...

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences PR Newswire WASHINGTON, Oct. 10, 2023 WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2023 financial results on Thursday, Nov. 2,...

Evolent Health to Participate in Upcoming Conferences PR Newswire WASHINGTON, Aug. 8, 2023 WASHINGTON , Aug. 8, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced that Chief Executive Officer Seth Blackley , Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in...

Evolent Announces Second Quarter 2023 Results PR Newswire WASHINGTON, Aug. 2, 2023 WASHINGTON , Aug. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended June 30, 2023 . Highlights from the second quarter 2023 announcement include: Revenue of $469.1 million , an increase of...

Evolent welcomes Toyin Ajayi to its Board of Directors PR Newswire WASHINGTON, July 26, 2023 Dr. Ajayi becomes the ninth independent board member; adds exceptional, relevant expertise as a CEO, physician, entrepreneur and advocate for improving health care quality and cost for underserved populations. WASHINGTON , July 26, 2023 /PRNewswire/ -- Evolent Health Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today...

Evolent to Release Second Quarter Financial Results on Wednesday, August 2, 2023 PR Newswire WASHINGTON, July 13, 2023 WASHINGTON , July 13, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today that it will release its second quarter 2023 financial results on Wednesday, August 2, 2023 , after market close, with a conference call to follow at 5 p.m. ET . Shareholders and...

Evolent Health announces focus on value-based specialty care with rebrand, unification of all solutions under "Evolent" PR Newswire WASHINGTON, July 11, 2023 Growth-focused company is a trusted partner for health plans and providers seeking to improve health outcomes across complex conditions. WASHINGTON , July 11, 2023 /PRNewswire/ -- Evolent Health ("the Company") (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced...